Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis

Benjamin Lockshin, Yevgeniy Balagula, Joseph F. Merola

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

In addition to being recognized as a chronic inflammatory disease that manifests in the skin, psoriasis is increasingly understood to be a systemic disease that causes immune dysregulation throughout the body. The systemic nature of psoriasis is evidenced by the higher burden of comorbidities and shorter life expectancies of patients with psoriasis, particularly those with early-onset and severe disease. Notably, psoriasis is associated with an increased risk for cardiovascular disease, which is the most common cause of morbidity and mortality in patients with psoriasis. In this review, we examine the association between psoriasis and cardiovascular disease and specifically focus on the role of interleukin 17–mediated inflammation as a potential mechanistic link between psoriasis and cardiovascular disease. Moreover, we describe potential treatment approaches to reduce the burden of cardiovascular disease in patients with psoriasis and discuss the clinical importance of the association of these 2 diseases with respect to patient management and education.

Original languageEnglish (US)
JournalJournal of the American Academy of Dermatology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Interleukin-17
Psoriasis
Inflammation
Cardiovascular Diseases
Interleukins
Immune System Diseases
Patient Education
Life Expectancy
Comorbidity
Chronic Disease
Morbidity
Skin
Mortality

Keywords

  • anti-inflammatory therapy
  • cardiovascular disease
  • comorbidities
  • IL-17
  • interleukin 17
  • psoriasis
  • systemic inflammation

ASJC Scopus subject areas

  • Dermatology

Cite this

Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis. / Lockshin, Benjamin; Balagula, Yevgeniy; Merola, Joseph F.

In: Journal of the American Academy of Dermatology, 01.01.2018.

Research output: Contribution to journalArticle

@article{f8599386539b4188961e0430d1988886,
title = "Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis",
abstract = "In addition to being recognized as a chronic inflammatory disease that manifests in the skin, psoriasis is increasingly understood to be a systemic disease that causes immune dysregulation throughout the body. The systemic nature of psoriasis is evidenced by the higher burden of comorbidities and shorter life expectancies of patients with psoriasis, particularly those with early-onset and severe disease. Notably, psoriasis is associated with an increased risk for cardiovascular disease, which is the most common cause of morbidity and mortality in patients with psoriasis. In this review, we examine the association between psoriasis and cardiovascular disease and specifically focus on the role of interleukin 17–mediated inflammation as a potential mechanistic link between psoriasis and cardiovascular disease. Moreover, we describe potential treatment approaches to reduce the burden of cardiovascular disease in patients with psoriasis and discuss the clinical importance of the association of these 2 diseases with respect to patient management and education.",
keywords = "anti-inflammatory therapy, cardiovascular disease, comorbidities, IL-17, interleukin 17, psoriasis, systemic inflammation",
author = "Benjamin Lockshin and Yevgeniy Balagula and Merola, {Joseph F.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jaad.2018.02.040",
language = "English (US)",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis

AU - Lockshin, Benjamin

AU - Balagula, Yevgeniy

AU - Merola, Joseph F.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - In addition to being recognized as a chronic inflammatory disease that manifests in the skin, psoriasis is increasingly understood to be a systemic disease that causes immune dysregulation throughout the body. The systemic nature of psoriasis is evidenced by the higher burden of comorbidities and shorter life expectancies of patients with psoriasis, particularly those with early-onset and severe disease. Notably, psoriasis is associated with an increased risk for cardiovascular disease, which is the most common cause of morbidity and mortality in patients with psoriasis. In this review, we examine the association between psoriasis and cardiovascular disease and specifically focus on the role of interleukin 17–mediated inflammation as a potential mechanistic link between psoriasis and cardiovascular disease. Moreover, we describe potential treatment approaches to reduce the burden of cardiovascular disease in patients with psoriasis and discuss the clinical importance of the association of these 2 diseases with respect to patient management and education.

AB - In addition to being recognized as a chronic inflammatory disease that manifests in the skin, psoriasis is increasingly understood to be a systemic disease that causes immune dysregulation throughout the body. The systemic nature of psoriasis is evidenced by the higher burden of comorbidities and shorter life expectancies of patients with psoriasis, particularly those with early-onset and severe disease. Notably, psoriasis is associated with an increased risk for cardiovascular disease, which is the most common cause of morbidity and mortality in patients with psoriasis. In this review, we examine the association between psoriasis and cardiovascular disease and specifically focus on the role of interleukin 17–mediated inflammation as a potential mechanistic link between psoriasis and cardiovascular disease. Moreover, we describe potential treatment approaches to reduce the burden of cardiovascular disease in patients with psoriasis and discuss the clinical importance of the association of these 2 diseases with respect to patient management and education.

KW - anti-inflammatory therapy

KW - cardiovascular disease

KW - comorbidities

KW - IL-17

KW - interleukin 17

KW - psoriasis

KW - systemic inflammation

UR - http://www.scopus.com/inward/record.url?scp=85045955280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045955280&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2018.02.040

DO - 10.1016/j.jaad.2018.02.040

M3 - Article

C2 - 29477740

AN - SCOPUS:85045955280

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

ER -